GSK to buy US cancer biotech Nuvalent for $10.6bn

As reported by International homepage

New chief Luke Miels makes his mark at GSK with one of UK drugmakers’ biggest deals

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on International homepage ↗

Market Samachar is a news aggregator. This article was originally published by International homepage. Tap the button above to read the full story on their site.

INDIAN Rupee gains as oil retreat soothes, inflow expectations erode weakening bias Markets-Economic Times
COMPANIES FPI inflows into FAR securities rise by Rs 8,795 cr after govt tax exemption move Stocks-Markets-Economic Times
COMPANIES Sensex rises 395 points, Nifty closes above 23,200; broader markets outperform Stocks-Markets-Economic Times
INDIAN SpaceX, Anthropic, OpenAI can rewrite history for megacap IPOs Markets-Economic Times
INDIAN Global Markets: European shares edge higher with banks in the lead; the Middle East in focus Markets-Economic Times
INDIAN Top Gainers & Losers on June 9: Gabriel India, OLA, Pine Labs, Bank of Baroda, Redington, Paytm among top gainers mint - markets
INDIAN Sensex snaps 2-day losing run, ends 395 points higher: 10 key highlights from Indian stock market today mint - markets
CRYPTO Humanity Protocol Loses $36M After Private Keys 'Compromised,' Token Crashes 73% Decrypt

GSK to buy US cancer biotech Nuvalent for $10.6bn

More from Market Samachar